Employees: 888
Size PROCEPT BioRobotics (PRCT) is a United States Health Care company (Medical Specialties) with a market value of $1.45B, the 1992nd largest of 3,085 United States companies the cockpit tracks. Shares closed at $25.18 on 18 Nov 2026.
Performance Over six months the shares fell 10.4%, against -7.0% for the median peer and -2.2% for the United States market (cap-weighted) — 9th lowest of 21 in its peer set.
Growth Revenue grew 17.5% over the last twelve months (peer median +10.8%); the operating margin is -33.6% (peer median 8.2%).
Valuation It trades at 3.7× enterprise value to sales against a peer median of 3.1× (9th most expensive of 21).
Capital Return on invested capital runs 59.1 points below its cost of capital (9.2% WACC).
Short interest Short interest is 13.7% of the free float (30 Oct 2026).
Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $352M | $308M | $224M | $136M | $75.0M |
| Revenue growth | — | +37% | +65% | +82% | — |
| Gross profit | $228M | $196M | $137M | $71.0M | $37.1M |
| EBITDA | -$110M | -$97.5M | -$91.4M | -$105M | -$76.4M |
| Net income | -$115M | -$95.6M | -$91.4M | -$106M | -$87.2M |
| Free cash flow | -$85.1M | -$58.3M | -$104M | -$133M | -$83.0M |
| Capital expenditure | $8.38M | $9.36M | $4.41M | $25.2M | $2.65M |
| Total debt | $77.0M | $78.5M | $80.2M | $79.2M | $77.3M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PRCT | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +33.8% | -1.6% | highest of 21 |
| 6-month return | -10.4% | -7.0% | 9th lowest of 21 |
| Distance from 52-week high | -33.9% | -28.4% | 9th lowest of 21 |
| Revenue growth (TTM) | +17.5% | +10.8% | 8th highest of 21 |
| Operating margin | -33.6% | 8.2% | 2nd lowest of 21 |
| EV / Sales | 3.7× | 3.1× | 9th most expensive of 21 |
| ROIC minus cost of capital | -59.1 pp | +0.5 pp | 3rd lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| PROCEPT BioRobotics PRCT | United States | $1.45B | -10% | +17% | -34% | 3.7× | n/a | n/a |
| Sinocare 300298.SZ | China | $1.45B | +4% | +7% | 6% | 2.0× | 9.5% | +18.3% |
| Inner Mongolia Furui Medical Science 300049.SZ | China | $1.45B | -31% | +11% | 25% | 6.0× | 2.9% | +14.6% |
| El.En ELN.MI | Italy | $1.46B | +11% | +3% | 15% | 2.1× | 10.7% | +7.7% |
| CONMED CNMD | United States | $1.43B | +30% | +2% | 2% | 1.6× | 31.6% | +9.8% |
| Shanghai MicroPort Endovascular MedTech 688016.SS | China | $1.55B | -19% | +16% | 44% | 5.7× | 2.7% | +23.4% |
| Nihon Kohden 6849.T | Japan | $1.55B | +3% | 0% | 7% | 0.9× | -3.5% | +3.3% |
| Enovis ENOV | United States | $1.56B | +2% | +3% | 4% | 1.3× | 20.0% | -6.0% |
| Vitrolife VITR.ST | Sweden | $1.57B | +13% | -2% | 19% | 4.9× | 22.2% | +22.5% |
| Wuxi Unicomp Technology 688531.SS | China | $1.58B | -49% | +53% | 12% | 6.9× | n/a | n/a |
| Ovctek China 300595.SZ | China | $1.33B | -25% | 0% | 28% | 3.8× | 8.3% | +16.5% |
| Cofoe Medical Technology 301087.SZ | China | $1.60B | -6% | +33% | 10% | 2.1× | 11.2% | +7.4% |
| Beijing Balance Medical Technology 688198.SS | China | $1.31B | -32% | +10% | 28% | 13.4× | 20.7% | +27.6% |
| Suzhou Sepax Technologies 688758.SS | China | $1.31B | +8% | +28% | 40% | 15.4× | 22.8% | +23.6% |
| Sonoscape Medical 300633.SZ | China | $1.31B | -10% | +18% | 4% | 3.3× | n/a | n/a |
| Angelalign Technology 6699.HK | Hong Kong | $1.62B | -8% | +84% | 9% | 3.0× | 16.7% | +25.8% |
| Butterfly Network BFLY | United States | $1.63B | +38% | +39% | -36% | 12.3× | n/a | n/a |
| STAAR Surgical STAA | United States | $1.27B | -23% | +42% | 7% | 3.4× | 35.1% | +7.9% |
| NovoCure NVCR | United States | $1.25B | -40% | +13% | -17% | 1.4× | n/a | n/a |
| NIPRO 8086.T | Japan | $1.68B | -11% | +5% | 5% | 1.3× | n/a | n/a |
| Inspire Medical Systems INSP | United States | $1.68B | +32% | 0% | 2% | 1.6× | 28.7% | +51.2% |